ICG Enterprise Trust plc (ICGT) Ordinary 10p Shares
Sell:1,304.00p
Buy:1,316.00p
0
Change:
12.00p
(0.92%)
12.00p
(0.92%)
FTSE 250:0.25%
Market closed |
Prices as at close on 20 December 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
- Add to watchlist
- Create an alert
- This stock can be held in a
Sell:1,304.00p
Buy:1,316.00p
Change:
12.00p
(0.92%)
12.00p
(0.92%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Market closed |
Prices as at close on 20 December 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Sell:1,304.00p
Buy:1,316.00p
Change:
12.00p
(0.92%)
12.00p
(0.92%)
Market closed |
Prices as at close on 20 December 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Objective
ICG Enterprise Trust will typically invest through: Primary Funds: commitments to private equity funds during their initial fund raise. Secondary Funds: acquiring interests in funds or investments after the fund’s initial fund raise accessed either directly or through a fund structure. Co-investments: investing alongside leading private equity managers, or directly, in specific private companies.
| Security | Weight |
|---|---|
| Minimax | 3.68% |
| Froneri | 2.70% |
| PetSmart | 2.41% |
| Datasite Global Corporation | 2.35% |
| Leaf Home Solutions | 1.88% |
| Visma | 1.87% |
| European Camping Group | 1.73% |
| Newton | 1.66% |
| Precisely | 1.55% |
| Curium Pharma | 1.52% |
Top 10 sectors currently unavailable.
Top 10 countries currently unavailable.
Fee Structure
Management fee is payable as a proportion of NAV at 1.25% p.a. for NAV less than GBP 1.5bn at 1.1% p.a. for NAV between GBP 1.5bn and GBP 2bn and at 1% p.a. for NAV greater than GBp 2bn.
Dividend Policy
The Company intends to pay dividend quarterly.
ASSET SPLIT
Trust Manager
Oliver Gardey
Manager Bio
Oliver has over 20 years’ experience in the private equity industry. For the past decade, he has been a partner at Pomona Capital where he was a member of the global investment committee. He was previously a partner at Adam Street and Rothschild/Five Arrows Capital respectively.
Board Of Directors
Jane TufnellChairman, Alastair Bruce, Gerhard Fusenig, David Warnock, Adiba Ighodaro, Janine Nicholls
Data policy - All information should be used for indicative purposes only. You should
independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete,
and accepts no responsibility for how it may be used.
Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.